ABSTRACT
The efficiency and stability of perovskite module devices are mainly limited by the quality of scalable perovskite films and sub-cells' lateral contact. Here, firstly, we report constant low temperature substrate to regulate the growth of perovskite intermediate films to slow down the crystallization for obtaining high-quality homogeneous perovskite films in large scale size, which avoid the effect of the ambient temperature on the film quality. Secondly, a scribing step named P1.5 was added before the top function layers deposition, the diffusion barrier layer can be formed "naturally" at the interconnection interface without introducing any additional materials, which well alleviates the diffusion degradation process. As a result, our inverted perovskite devices exhibit a very small efficiency loss with area expansion comparable to other photovoltaic devices (for example, Cadmium Telluride), the perovskite module (aperture area 14.61 cm2) shows a certified quasi-steady-state power conversion efficiency of 22.73%, and the module maintaining over 90% of its initial efficiency after 1000 hours of continuous operation under illumination.
ABSTRACT
We developed and experimentally realized a scheme of optical nonreciprocity (ONR) by using degenerate two-level atoms embedded in an optical ring cavity. For the degenerate transition Fg = 4 â Fe = 3, we first studied the cavity-transmission property in different coupling field configurations and verified that under the strong-coupling regime, the single-dark-state peak formed by electromagnetically induced transparency (EIT) showed ONR. The stable ground-state Zeeman coherence for Λ-chains involved in the degenerate two-level system was found to be important in the formation of intracavity EIT. However, different from the three-level atom-cavity system, in the degenerate two-level system, the ONR effect based on intracavity EIT occurred only at a low probe intensity, because the cavity-atom coupling strength was weakened in the counter-propagating probe and coupling field configuration. Furthermore, ONR transmission with a high contrast and linewidth-narrowing was experimentally demonstrated.
ABSTRACT
AIM: For patients with locally advanced rectal cancer, previous STELLAR studies have shown that a new adjuvant treatment paradigm of short-course radiotherapy followed by neoadjuvant chemotherapy can achieve pathological complete response rates superior to those of standard care; however, the 3-year DFS is inferior to neoadjuvant concurrent radiotherapy. Recent studies have shown that immune checkpoint inhibitors may improve the prognosis of rectal cancer and have good synergy with radiotherapy. Therefore, neoadjuvant chemotherapy combined with immune checkpoint inhibitors after a short course of radiotherapy has the potential to further improve complete response rates and prognosis. METHOD: The STELLAR II study is a multicentre, open label, two-arm randomized, phase II/III trial of short-course radiotherapy followed by neoadjuvant chemotherapy concurrent with immunotherapy for locally advanced rectal cancer. A total of 588 patients with locally advanced rectal cancer (LARC) will be randomly assigned to the experimental and control groups. The experimental group will receive short-course radiotherapy and neoadjuvant chemotherapy in combination with sindilizumab, while the control group will receive short-course radiotherapy and neoadjuvant chemotherapy. Both groups will subsequently receive either total rectal mesenteric resection or a watch & wait (W&W) strategy. The phase II primary endpoint is the complete remission rate, and the secondary endpoints include grade 3-4 adverse events, perioperative complications, R0 resection rate, overall survival, local recurrence rate, distant metastasis rate and quality of life score. A seamless phase II/III randomized controlled design will be used to investigate the effectiveness and safety of the TNT strategy with the addition of immunotherapy. The trial opened, and the first patient was recruited on 31 August 2022. Trial registration number and date of registration: ClinicalTrials.gov NCT05484024, 29 July 2022. DISCUSSION: The STELLAR II trial will prospectively evaluate the efficacy of TNT treatment strategies that incorporate immune checkpoint inhibitors. The trial will yield important information to guide routine management of patients with local advanced rectal cancer.
ABSTRACT
Phytoplankton community characterized by strong vitality response to environmental change in freshwater ecosystems. This study aims to evaluate the effectiveness of using phytoplankton diversity as a water quality indicator in wetlands, and find out the main environmental variables affecting the distribution of phytoplankton. From 2020 to 2021, we examined phytoplankton assemblages and water environmental variables in spring, summer, and autumn at eight sampling sites from Hulanhe Wetland, Northeast (NE) China. The results showed that Bacillariophyta was the dominant species. Phytoplankton composition and abundance differed among sampling sites in each season; the abundance in summer (613.71 × 104 ind. L-1) was higher than that in autumn and spring. The water quality assessment of the trophic state index (TSI) based on the four physicochemical indicators was compared with phytoplankton diversity indices, which indicated that the phytoplankton community was stable, and these two indices were significantly lower in summer than in spring and autumn. According to redundancy analysis (RDA), total phosphorus (TP) and nitrogen (TN) were the main environmental variables affecting the distribution of phytoplankton. Temperature and dissolved oxygen (DO) changes also played a role, and their impact on the community was discussed. This work can provide relevant scientific references on the usefulness of phytoplankton diversity structure in assessing water quality in cold regions, in which the succession can be significantly affected by nutrients and temperatures.
Subject(s)
Fresh Water , Phytoplankton , Seasons , Water Quality , Wetlands , Phytoplankton/growth & development , China , Fresh Water/analysis , Phosphorus/analysis , Biodiversity , Environmental Monitoring/methods , Nitrogen/analysis , TemperatureABSTRACT
The frequency evaluation of collimated blue light (CBL) generated by parametric four-wave mixing (FWM) in hot atomic vapor is presented. The cesium (133Cs) atoms are excited from the 6S1/2 ground state to 8S1/2 excited state with the 852 and 795â nm pump lasers, producing an optical field at 4.2â µm through an amplified spontaneous emission via population inversion on the 8S1/2 â 7P3/2 transition and the 456â nm CBL via FWM on the 7P3/2 â 6S1/2 transition. The frequency shift of 456â nm CBL has been measured by velocity-selective optical pumping spectral technique when the frequency of any one of two pumping lasers is tuned. The ratio of the frequency shift of 456â nm CBL to the two-photon frequency detuning of two pumping lasers is 0.8912, implying that the generated 4.2â µm light frequency is also correspondingly shifted.
ABSTRACT
Fetal adenocarcinoma of the lung (FLAC) is a rare form of lung adenocarcinoma and was divided into high-grade (H-FLAC) and low-grade (L-FLAC) subtypes. Despite the existence of some small case series studies, a comprehensive multi-omics study of FLAC has yet to be undertaken. In this study, we depicted the multi-omics landscapes of this rare lung cancer type by performing multi-regional sampling on 20 FLAC cases. A comparison of multi-omics profiles revealed significant differences between H-FLAC and L-FLAC in a multi-omic landscape. Two subtypes also showed distinct relationships between multi-layer intratumor heterogeneity (ITH). We discovered that a lower genetic ITH was significantly associated with worse recurrence-free survival and overall survival in FLAC patients, whereas higher methylation ITH in H-FLAC patients suggested a short survival. Our findings highlight the complex interplay between genetic and transcriptional heterogeneity in FLAC and suggest that different types of ITH may have distinct implications for patient prognosis.
ABSTRACT
BACKGROUND: The purpose of this study was to evaluate the safety and efficacy of preoperative concurrent chemoradiotherapy (preCRT) for locally advanced rectal cancer in older people who were classified as "fit" by comprehensive geriatric assessment (CGA). METHODS: A single-arm, multicenter, phase II trial was designed. Patients were eligible for this study if they were aged 70 years or above and met the standards of "fit" (SIOG1) as evaluated by CGA and of the locally advanced risk category. The primary endpoint was 2-year disease-free survival (DFS). Patients were scheduled to receive preCRT (50 Gy) with raltitrexed (3 mg/m2 on days 1 and 22). RESULTS: One hundred and nine patients were evaluated by CGA, of whom eighty-six, eleven and twelve were classified into the fit, intermediate and frail category. Sixty-eight fit patients with a median age of 74 years were enrolled. Sixty-four patients (94.1%) finished radiotherapy without dose reduction. Fifty-four (79.3%) patients finished the prescribed raltitrexed therapy as planned. Serious toxicity (grade 3 or above) was observed in twenty-four patients (35.3%), and fourteen patients (20.6%) experienced non-hematological side effects. Within a median follow-up time of 36.0 months (range: 5.9-63.1 months), the 2-year overall survival (OS), cancer-specific survival (CSS) and disease-free survival (DFS) rates were 89.6% (95% CI: 82.3-96.9), 92.4% (95% CI: 85.9-98.9) and 75.6% (95% CI: 65.2-86.0), respectively. Forty-eight patients (70.6%) underwent surgery (R0 resection 95.8%, R1 resection 4.2%), the corresponding R0 resection rate among the patients with positive mesorectal fascia status was 76.6% (36/47). CONCLUSION: This phase II trial suggests that preCRT is efficient with tolerable toxicities in older rectal cancer patients who were evaluated as fit based on CGA. TRIAL REGISTRATION: The registration number on ClinicalTrials.gov was NCT02992886 (14/12/2016).
Subject(s)
Chemoradiotherapy , Geriatric Assessment , Rectal Neoplasms , Humans , Aged , Male , Female , Rectal Neoplasms/therapy , Aged, 80 and over , Geriatric Assessment/methods , Chemoradiotherapy/methods , Disease-Free Survival , Preoperative Care/methods , Thiophenes/administration & dosage , Thiophenes/therapeutic use , Patient Care Team , Quinazolines/administration & dosage , Quinazolines/therapeutic useABSTRACT
In previously reported researches on bound state in the continuum (BIC) waveguides, almost all of them are demonstrated with top-down fabrication procedures, leading to inconvenience for post-manipulation and size tuning. Nanofibers with circular cross sections are the fundamental components to transport energy due to their intrinsic advantages of high flexibility and adjustability, which is replaceable and can be readily manipulated over size and position on the substrate. In this work, we explore the possibility of achieving on-chip integration of silica nanofiber onto a silicon-on-insulator platform. By constructing additional leakage channels in coupled nanofiber waveguides, coherently destructive interferences are successfully achieved. The heavy leakage losses from the low-index nanofiber to a high-index silicon substrate are completely eliminated with BIC, and the propagation length of the nanofiber waveguide is significantly improved.
ABSTRACT
BACKGROUND: For patients with locally advanced rectal cancer (LARC), total neoadjuvant therapy (TNT), namely, intensifying preoperative treatment through the integration of radiotherapy and systemic chemotherapy before surgery, was commonly recommended as the standard treatment. However, the risk of distant metastasis at 3 years remained higher than 20%, and the complete response (CR) rate was less than 30%. Several clinical trials had suggested a higher complete response rate when combining single-agent immunotherapy with short-course radiotherapy (SCRT). The CheckMate 142 study had shown encouraging outcomes of dual immunotherapy and seemingly comparable toxicity for CRC compared with single-agent immunotherapy in historical results. Therefore, dual immunotherapy might be more feasible in conjunction with the TNT paradigm of SCRT. We performed a phase II study to investigate whether the addition of a dual immune checkpoint inhibitor bispecific antibody, Cadonilimab, to SCRT combined with chemotherapy might further increase the clinical benefit and prognosis for LARC patients. METHODS: This single-arm, multicenter, prospective, phase II study included patients with pathologically confirmed cT3-T4N0 or cT2-4N + rectal adenocarcinoma with an ECOG performance score of 0 or 1. Bispecific antibody immunotherapy was added to SCRT combined with chemotherapy. Patients enrolled would be treated with SCRT (25 Gy in five fractions over 1 week) for the pelvic cavity, followed by 4 cycles of CAPOX or 6 cycles of mFOLFOX and Cadonilimab. The primary endpoint was the CR rate, which was the ratio of the pathological CR rate plus the clinical CR rate. The secondary endpoints included local-regional control, distant metastasis, disease-free survival, overall survival, toxicity profile, quality of life and functional outcome of the rectum. To detect an increase in the complete remission rate from 21.8% to 40% with 80% power, 50 patients were needed. DISCUSSION: This study would provide evidence on the efficacy and safety of SCRT plus bispecific antibody immunotherapy combined with chemotherapy as neoadjuvant therapy for patients with LARC, which might be used as a candidate potential therapy in the future. TRIAL REGISTRATION: This phase II trial was prospectively registered at ClinicalTrials.gov, under the identifier NCT05794750.
Subject(s)
Rectal Neoplasms , Rectum , Humans , Rectum/pathology , Prospective Studies , Quality of Life , Rectal Neoplasms/drug therapy , Rectal Neoplasms/radiotherapy , Neoadjuvant Therapy/methods , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Chemoradiotherapy/methods , Neoplasm Staging , Clinical Trials, Phase II as Topic , Multicenter Studies as TopicABSTRACT
Objective: This study aims to establish the precise prevalence of sleep disorders among university students in Jiangsu Province. Utilizing a representative sample of students, we measured their sleep quality based on the Pittsburgh Sleep Quality Index (PSQI). Our objective is to quantitatively assess the magnitude of sleep quality and identify key factors. By detailed analysis of these relationships, our study seeks to provide actionable insights for the development of targeted interventions to enhance sleep quality within this population. Methods: From October to November 2022, we conducted a cross-sectional web-based survey in Jiangsu Province, China. Using convenient cluster sampling in each college, a total of 8457 participants were selected. The PSQI was applied to assess sleep quality among university students. Data collected included sociodemographic details, scores from the Mobile Phone Dependence Index (MPAI) and psychological resilience measured by the Connor-Davidson Resilience Scale (CD-RISC). Results: The overall prevalence of poor sleep quality among the participants was 39.30%. Binary logistic regression analysis revealed that higher physical activity (OR = 0.921; 95% CI: 0.779-1.090), earlier roommate bedtimes (OR = 0.799; 95% CI: 0.718-0.888), quieter dormitories (OR = 0.732; 95% CI: 0.647-0.828) and higher psychological resilience (OR = 0.982; 95% CI, 0.979-0.984) were protective factors linked to lower risk of poor sleep quality. Conversely, being a female student (OR = 1.238; 95% CI: 1.109-1.382), being a senior (OR = 1.582; 95% CI: 1.344-1.863), single-child status (OR = 1.195; 95% CI: 1.077-1.326), regular smoking (OR = 1.833; 95% CI: 1.181-2.847), regular alcohol consumption (OR = 1.737; 95% CI: 1.065-2.833), high academic stress (OR = 1.326; 95% CI: 1.012-1.736), high employment stress (OR = 1.352; 95% CI: 1.156-1.582), dissatisfaction with dormitory hygiene (OR = 1.140; 95% CI: 1.028-1.265), poor self-rated physical health (OR = 1.969; 95% CI: 1.533-2.529), poor self-rated mental health (OR = 2.924; 95% CI: 2.309-3.702) and higher mobile phone dependency were risk factors associated with an increased likelihood of poor sleep quality. Conclusion: The sleep quality among university students should attract immediate attention. The development of public services and mental health education initiatives is crucial in enhancing the sleep health of this population.
ABSTRACT
Developing luminogens with a high emission efficiency in both single-molecule and aggregate states, as well as high mobility, shows promise for advancing the iteration and update of organic optoelectronic materials. However, achieving a delicate balance between the plane configuration of luminophores and the strong exciton interactions of aggregates is a formidable task from the molecular design perspective. This dilemma was overcome by integrating a rigid donor and flexible acceptor to establish donor-acceptor (D-A) type emitters. The π-conjugate-extended donor ensures the substantial planarity of these molecules, allowing strong emission in solution with photoluminescence quantum yield values of 86% and 75%. Furthermore, the restricted molecular motion of the aggregation-induced emission moiety and the formation of J-aggregates reduce the quenching effect, leading to a high emissive efficiency of 85% and 91% in the aggregate state. The mildly distorted D-A geometry builds moderate electrostatic interaction, resulting in high mobility with µM,h of 7.12 × 10-5 and 3.27 × 10-4 cm2/V s. Additionally, an improved synthesized procedure for terminal E-configured acrylonitrile with metal-free and concise reaction conditions is presented. The successful application of the synthesized compounds in organic light-emitting diode devices demonstrates the practicability of the molecular design strategy with connecting a rigid donor and flexible acceptor.
ABSTRACT
Poor mechanical strength at working temperature and low ionic conductivity seriously hinder the application of poly(ethylene oxide) (PEO)-based solid polymer electrolytes (SPEs) in high performance all-solid-state lithium metal batteries (LMBs). Here, we design and prepare a series of rigid-flexible coupling network SPEs (RFN-SPEs) with soft poly(ethylene glycol) (PEG) chains and rigid crosslinkers containing the benzene structure. Compared with soft crosslinkers, rigid crosslinkers provide the same amount of active crosslinking points with smaller molecular weight, and meanwhile enhance the mechanical strength of the network. Therefore, based on the rigid crosslinkers, RFN-SPEs exhibit synchronously improved ionic conductivity and mechanical strength. With these RFN-SPEs, symmetrical cells can be cycled for over 2100 h at 0.5 mA cm-2. Meanwhile, stable cycling and high-rate capability could be achieved for LMBs, revealing that SPEs with the rigid-flexible coupling network are promising electrolyte systems for all-solid-state LMBs.
ABSTRACT
We demonstrate the generation of polychromatic and collimated lights at 456â nm, 459â nm, and 761â nm based on cesium (133Cs) 6S1/2 - 6P3/2 - 8S1/2 - 7P3/2, 7P1/2, 6P1/2 - 6S1/2 multi-diamond-type atomic system via two-photon excitation with two IR pump lasers at 852â nm and 795â nm. The 456â nm, 459â nm (7P3/2, 7P1/2 â 6S1/2) collimated blue lights result from the self-seeded four-wave mixing process (FWM), and the 761â nm coherent light (8S1/2 â 6P1/2) is from a seeded FWM process with the injection of a third laser at 895â nm. We measure the dependency of generated polychromatic fields on the temperature of 133Cs vapor cell and the powers of input lasers, clearly demonstrating the competition between the self-seeded FWM and seeded FWM, as they share the same excitation path. This work is helpful to further produce entangled multi-color photons for quantum communication.
ABSTRACT
Diabetes mellitus (DM) is a serious chronic metabolic disease that can lead to many serious complications, such as cardiovascular disease, retinopathy, neuropathy, and kidney disease. Once diagnosed with diabetes, patients need to take oral hypoglycemic drugs or use insulin to control blood sugar and slow down the progression of the disease. This has a significant impact on the daily life of patients, requiring constant monitoring of the side effects of medication. It also imposes a heavy financial burden on individuals, their families, and even society as a whole. Adipose-derived stem cells (ADSCs) have recently become an emerging therapeutic modality for DM and its complications. ADSCs can improve insulin sensitivity and enhance insulin secretion through various pathways, thereby alleviating diabetes and its complications. Additionally, ADSCs can promote tissue regeneration, inhibit inflammatory reactions, and reduce tissue damage and cell apoptosis. The potential mechanisms of ADSC therapy for DM and its complications are numerous, and its extensive regenerative and differentiation ability, as well as its role in regulating the immune system and metabolic function, make it a powerful tool in the treatment of DM. Although this technology is still in the early stages, many studies have already proven its safety and effectiveness, providing new treatment options for patients with DM or its complications. Although based on current research, ADSCs have achieved some results in animal experiments and clinical trials for the treatment of DM, further clinical trials are still needed before they can be applied in a clinical setting.
Subject(s)
Diabetes Mellitus, Experimental , Animals , Humans , Diabetes Mellitus, Experimental/metabolism , Adipose Tissue , Adipocytes/metabolism , Blood Glucose/metabolism , Stem Cells/metabolismABSTRACT
Pathological cardiac hypertrophy is an independent risk factor for heart failure. Disruption of mitochondrial protein homeostasis plays a key role in pathological cardiac hypertrophy; however, the mechanism of maintaining mitochondrial homeostasis in pathological cardiac hypertrophy remains unclear. In this study, we investigated the regulatory mechanisms of mitochondrial protein homeostasis in pathological cardiac hypertrophy. Wildtype (WT) mice, knockout mice, and mice transfected with lentivirus overexpressing mouse C1q-tumor necrosis factor-related protein-3 (CTRP3) underwent transverse aortic constriction or sham surgery. After 4 weeks, cardiac function, mitochondrial function, and oxidative stress injury were examined. For mechanistic studies, neonatal rat cardiomyocytes were treated with small interfering RNA or overexpression plasmids for the relevant genes. CTRP3 overexpression attenuated transverse aortic constriction (TAC) induced pathological cardiac hypertrophy, mitochondrial dysfunction, and oxidative stress injury compared to that in WT mice. TAC or Ang II resulted in compensatory activation of UPRmt, but this was not sufficient to counteract pathologic cardiac hypertrophy. CTRP3 overexpression further induced activation of UPRmt during pathologic cardiac hypertrophy and thereby alleviated pathologic cardiac hypertrophy, whereas CTRP3 knockout or knockdown inhibited UPRmt. ATF5 was a key regulatory molecule of UPRmt, as ATF5 knockout prevented the cardioprotective effect of CTRP3 in TAC mice. In vitro, SIRT1 was identified as a possible downstream CTRP3 effector molecule, and SIRT1 knockout blocked the cardioprotective effects of CTRP3. Our results also suggest that ATF5 may be regulated by SIRT1. Our study demonstrates that CTRP3 activates UPRmt via the SIRT1/ATF5 axis under pathological myocardial hypertrophy, thus attenuating mitochondrial dysfunction and oxidative stress injury.
ABSTRACT
INTRODUCTION: While intracorporeal anastomosis (IA) has been widely used in totally laparoscopic right colectomy, its application in laparoscopic segmental left colectomy for splenic flexure cancer remains underexplored, particularly in large-scale studies with long-term outcomes. This research aims to assess the technical feasibility and oncological efficacy of IA in treating colonic splenic flexure carcinoma, drawing insights from both short-term and long-term outcomes of a retrospective cohort. MATERIALS AND METHODS: A retrospective analysis was conducted on 342 patients diagnosed with colonic splenic flexure carcinoma in three Chinese medical centers. These patients underwent laparoscopic segmental left colectomy between December 2014 and December 2019 across three medical institutions. Comprehensive data encompassing demographics, disease features, pathological characteristics, operative details, and both short-term and long-term outcomes were gathered and scrutinized. Using propensity scores, each patient from the IA cohort was paired with a counterpart from the extracorporeal anastomosis (EA) cohort. RESULTS: IA was performed on 129 patients, while 213 underwent EA. Post-propensity score matching resulted in 129 matched pairs. After matching, many baseline characteristics were balanced. The IA cohort exhibited several advantages, including shorter incision lengths ( P <0.001) and more extensive proximal and distal resection margins ( P =0.003, P <0.001). Additionally, the IA method facilitated a more rapid postoperative recovery as indicated by quicker return of bowel movements (resumption of passing flatus [2.7 (1.0-7.0) days vs. 3.3 (2.0-8.0) days, P <0.001] and defecation [3.7 (1.0-9.0)] days vs. 4.5 (2.0-9.0) days, P <0.001]), faster discharges [6.6 (3.0-15.0) days vs. 8.3 (5.0-20.0) days, P <0.001], and decreased need for rescue analgesics ( P <0.001). The rate of postoperative complications, as rated by the Clavien-Dindo classification, remained consistent across both techniques ( P =0.087). Furthermore, the cosmetic outcome rated by Patient Scar Assessment Questionnaire and Scoring System (PSAQ) was markedly superior in the IA group ( P <0.001). Both approaches demonstrated equivalent 5-year overall (82.7% vs. 82.1%, P =0.419) and disease-free survival (80.9% vs. 78.1%, P =0.476). Subsequent stratification analysis revealed that IA achieved comparable 5-year overall (80.7% vs. 82.0%, P =0.647) and disease-free survival (78.1% vs. 76.4%, P =0.734) in patients with locally advanced colon cancer. CONCLUSION: Employing IA for laparoscopic segmental left colectomy in cases of splenic flexure carcinoma is not only safe but also offers enhanced cosmetic results and expedited postoperative recovery. Oncologically speaking, IA in left segmental colectomy for splenic flexure carcinoma can yield therapeutic outcomes comparable to those of EA, even in patients with locally advanced colon cancer.
Subject(s)
Carcinoma , Colon, Transverse , Colonic Neoplasms , Laparoscopy , Splenic Neoplasms , Humans , Colon, Transverse/surgery , Retrospective Studies , Treatment Outcome , Laparoscopy/adverse effects , Laparoscopy/methods , Colonic Neoplasms/surgery , Splenic Neoplasms/surgery , Colectomy/adverse effects , Colectomy/methods , Anastomosis, Surgical/methods , Carcinoma/surgeryABSTRACT
Aqueous Zn-ion batteries (ZIBs) are promising candidates for large-scale energy storage due to high safety, abundant reserves, low-cost, and high energy density. However, the reversibility of the metallic Zn anode in the mild electrolyte is still unsatisfactory, due to the Zn dendrite growth, hydrogen evolution, and corrosion passivation. Herein, a Zn-In alloying powder solvent free electrode is proposed to replace the Zn foil in ZIBs. The novel Zn anodes are constructed by a solvent-free manufacturing process with carbons, forming a 3D Zn deposition network and providing uniformly electric field distribution. The In on the Zn powder surface can increase the overpotential for hydrogen evolution and further improve the morphology of Zn deposition against dendrite growth. The Zn solvent-free electrodes enable the Zn-MnO2 batteries with high cathode loading mass of 10-20 mg cm-2 to achieve >380 stable cycles. Furthermore, the assembled soft package batteries of 2.4 Ah (52 Wh kg-2 ) is evaluated and the capacity retention is maintained at 80% after 200 cycles at a high areal capacity of 5 mAh cm-2 without gas evolution. This work offers a workable strategy to develop a durable Zn anode for the eventually commercial applications of aqueous Zn-Mn secondary batteries.
ABSTRACT
Conventional laparoscopic-assisted right hemicolectomy requires a small abdominal incision to extract the specimen, which becomes an important source of postoperative complications and impairs perioperative experience. Transvaginal natural orifice specimen extraction surgery (NOSES VIIIA) avoids this small incision by extracting the specimen through the vagina. Here we describe the design of a multicenter, open-label, parallel, noninferior, phase III randomized controlled trial (NCT05495048). The aim of this study is to confirm that the NOSES VIIIA procedure is not inferior to small-incision assisted right hemicolectomy in long-term oncological efficacy. A total of 352 female patients with right colon adenocarcinoma/high-grade intraepithelial neoplasia will be randomly assigned to the NOSES VIIIA arm and the small-incision arm in a 1:1 ratio. The primary end point of this trial is 3 year disease-free survival. Clinical Trial Registration: NCT05495048 (ClinicalTrials.gov).
Subject(s)
Adenocarcinoma , Colonic Neoplasms , Laparoscopy , Natural Orifice Endoscopic Surgery , Female , Humans , Adenocarcinoma/surgery , Clinical Trials, Phase III as Topic , Colectomy/adverse effects , Colonic Neoplasms/surgery , Laparoscopy/adverse effects , Laparoscopy/methods , Multicenter Studies as Topic , Natural Orifice Endoscopic Surgery/adverse effects , Natural Orifice Endoscopic Surgery/methods , Randomized Controlled Trials as Topic , Treatment Outcome , Equivalence Trials as TopicABSTRACT
IL/ICOF composites were in situ synthesized via a one-pot route in half an hour under ambient conditions for catalytic cycloaddition of CO2 with epoxides into cyclic carbonates. The prepared composites feature a decent CO2 adsorption capacity of 1.63 mmol g-1 at 273 K and 1 bar and exhibit excellent catalytic performance in terms of yield and durability. This work may pave a new way to design and construct functionalized porous organic frameworks as heterogeneous catalysts for CO2 capture and conversion.